Cells constantly monitor and recycle their proteins through a tightly regulated waste-disposal system. Proteins that are no ...

A newly discovered link between pancreatic cancer and neural signaling reveals a promising drug target that slows tumor ...

Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to ...

Researchers say study results provide a clear rationale for developing therapies that target LCN2 in lung cancer patients.

Researchers at the Johns Hopkins Kimmel Cancer Center have discovered how certain pathogenic bacteria in gut and breast ...

Targeted Oncology: For the community oncologist, the choice between niraparib and olaparib often comes down to the patient's molecular profile. In a pMMR/HRD-negative patient, what clinical markers ...

Researchers at City St. George’s, University of London, have identified a new molecular signature that may explain why patients with aggressive HER2-positive breast cancer developed resistance to ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are emerging as important for guiding ovarian cancer therapy, including ...